CPIC assigns CPIC levels to genes/drugs with (1) PharmGKB Clinical Annotation Levels of Evidence of 1A, 1B, 2A and 2B, or (2) a PharmGKB PGx level for FDA-approved drug labels of “actionable pgx”, “genetic testing recommended”, or “genetic testing required”, or (3) based on nomination to CPIC for consideration.
- View CPIC’s process for assigning CPIC levels
- View CPIC’s levels for genes/drugs
- View CPIC’s process for prioritizing CPIC guidelines
CPIC invites feedback on existing and planned gene/drug guidelines.